Purchase Order 80NSSC22PA131

The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs....

This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support...

The federal contract award is for SUPERDEX 75 PREP GRADE 26/60, CAT# 17-1070-01. The prime contractor is a domestic awardee doing business as Federal Egov IAE Initiative - Generic Entity Identifier. The contract type is a Blanket Purchase Agreement call placed under an indefinite delivery/indefinite quantity contract vehicle. Performance will take place in Bethesda, Maryland. The start date is August 13, 2009 with an unknown end date. Pricing is other than firm-fixed-price. The funding agency is...

This federal contract award to Sartorius Stedim North America Inc. is for the procurement of two AMBR 250 high throughput bioreactor systems for the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Production Program (VPP). The $4,507,574 firm fixed price purchase order requires delivery within 65 days. The bioreactor systems must meet specific technical requirements to support NIAID's mammalian cell culture research and development. This contract is not set aside for any...

This is a delivery order awarded by the National Institute on Drug Abuse (part of the National Institutes of Health under the Department of Health and Human Services) to Bachem Americas, Inc., a foreign-owned for-profit manufacturer of pharmaceutical ingredients. The $1,050,039.90 firm fixed-price contract is for the manufacture of 200 grams of current Good Manufacturing Practice (cGMP) parathyroid hormone-related protein (PTH-rP). The work is being conducted under the parent "CRO Support...

The National Institute of Standards and Technology (NIST) awarded a $500,000 firm fixed-price purchase order to Sigma-Aldrich, Inc., doing business as Sigma-Aldrich Sales, Inc., for the manufacturing of a monoclonal antibody expressed from the NISTCHO cell line. The contract has no set-aside designation and is expected to be completed by August 5, 2026. Sigma-Aldrich, a foreign-owned, for-profit organization, will deliver the monoclonal antibody at a concentration of 100 mg/mL in L-Histidine....

This federal contract award is for a HIGH PERFORMANCE ANION EXCHANGE CHROMATOGRAPHY-PULSED AMPEROMETRIC DETECTION (HPAEC-PAD) SYSTEM, awarded to Thermo Electron North America LLC, a For Profit Organization and Limited Liability Company. The contract was awarded on August 27, 2024 by the U.S. Department of Agriculture's Agricultural Research Service, a civilian agency, with a ceiling value of $110,680.42 and an ultimate completion date of October 31, 2027. The contract was awarded under the...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for gene synthesis, expression, and purification services valued at $11,211.10. The contract was awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) and does not have a set-aside designation. The contract supports the production of recombinant mouse monoclonal IgE antibodies that can recognize and distinguish between nut allergens Ana o 3 and Car i 1....

This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded Promab Biotechnologies, Inc. a $16,630.00 firm fixed-price purchase order for antibody production services. This contract had a small business set-aside designation and was performed in Richmond, California, with a completion date of August 6, 2021. Promab Biotechnologies is a minority-owned, Asian-Pacific American-owned, for-profit small business that develops and commercializes recombinant...